U.S. flag

An official website of the United States government

NM_001330078.2(NRXN1):c.772+1140G>A AND not specified

Germline classification:
Benign (4 submissions)
Last evaluated:
Jan 27, 2020
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000117842.14

Allele description [Variation Report for NM_001330078.2(NRXN1):c.772+1140G>A]

NM_001330078.2(NRXN1):c.772+1140G>A

Gene:
NRXN1:neurexin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_001330078.2(NRXN1):c.772+1140G>A
HGVS:
  • NC_000002.12:g.51026362C>T
  • NG_011878.1:g.11175G>A
  • NM_001135659.3:c.871+9G>A
  • NM_001330077.2:c.772+1140G>A
  • NM_001330078.2:c.772+1140G>AMANE SELECT
  • NM_001330079.2:c.772+1140G>A
  • NM_001330081.2:c.772+1140G>A
  • NM_001330082.2:c.772+1140G>A
  • NM_001330083.2:c.772+1140G>A
  • NM_001330084.2:c.772+1140G>A
  • NM_001330085.2:c.772+1140G>A
  • NM_001330086.2:c.772+1140G>A
  • NM_001330087.2:c.772+1140G>A
  • NM_001330088.2:c.772+1140G>A
  • NM_001330089.2:c.772+1140G>A
  • NM_001330090.2:c.772+1140G>A
  • NM_001330093.2:c.772+1140G>A
  • NM_001330094.2:c.772+1140G>A
  • NM_001330095.2:c.772+1140G>A
  • NM_001330096.2:c.772+1140G>A
  • NM_004801.6:c.772+1140G>A
  • NC_000002.11:g.51253500C>T
  • NM_001135659.1:c.871+9G>A
  • NM_001135659.2:c.871+9G>A
Links:
dbSNP: rs61658382
NCBI 1000 Genomes Browser:
rs61658382
Molecular consequence:
  • NM_001135659.3:c.871+9G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330077.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330078.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330079.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330081.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330082.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330083.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330084.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330085.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330086.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330087.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330088.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330089.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330090.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330093.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330094.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330095.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330096.2:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_004801.6:c.772+1140G>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000152113Genetic Services Laboratory, University of Chicago
no assertion criteria provided
Likely benigngermlineclinical testing

SCV000170812GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Benign
(Jan 25, 2013)
germlineclinical testing

Citation Link,

SCV001475327Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Benign
(Jan 27, 2020)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001984107Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(Jan 2, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Karbassi I, Maston GA, Love A, DiVincenzo C, Braastad CD, Elzinga CD, Bright AR, Previte D, Zhang K, Rowland CM, McCarthy M, Lapierre JL, Dubois F, Medeiros KA, Batish SD, Jones J, Liaquat K, Hoffman CA, Jaremko M, Wang Z, Sun W, Buller-Burckle A, et al.

Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.

PubMed [citation]
PMID:
26467025
PMCID:
PMC4737317

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Genetic Services Laboratory, University of Chicago, SCV000152113.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV000170812.11

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Athena Diagnostics, SCV001475327.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital, SCV001984107.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024